La Jolla Pharmaceutical Company (LJPC) Income Quarterly - Discounting Cash Flows
LJPC
La Jolla Pharmaceutical Company
LJPC (NASDAQ)
Period Ending: LTM
(Last Twelve Months)
2022 (Q2)
06-30
2022 (Q1)
03-31
2021 (Q4)
12-31
2021 (Q3)
09-30
2021 (Q2)
06-30
2021 (Q1)
03-31
2020 (Q4)
12-31
2020 (Q3)
09-30
2020 (Q2)
06-30
2020 (Q1)
03-31
2019 (Q4)
12-31
2019 (Q3)
09-30
2019 (Q2)
06-30
2019 (Q1)
03-31
2018 (Q4)
12-31
2018 (Q3)
09-30
2018 (Q2)
06-30
2018 (Q1)
03-31
2017 (Q4)
12-31
2017 (Q3)
09-30
2017 (Q2)
06-30
2017 (Q1)
03-31
2016 (Q4)
12-31
2016 (Q3)
09-30
2016 (Q2)
06-30
2016 (Q1)
03-31
2015 (Q4)
12-31
2015 (Q3)
09-30
2015 (Q2)
06-30
2015 (Q1)
03-31
2014 (Q4)
12-31
2014 (Q3)
09-30
2014 (Q2)
06-30
2014 (Q1)
03-31
2013 (Q4)
12-31
2013 (Q3)
09-30
2013 (Q2)
06-30
2013 (Q1)
03-31
2012 (Q4)
12-31
2012 (Q3)
09-30
2012 (Q2)
06-30
2012 (Q1)
03-31
2011 (Q4)
12-31
2011 (Q3)
09-30
2011 (Q2)
06-30
2011 (Q1)
03-31
2010 (Q4)
12-31
2010 (Q3)
09-30
2010 (Q2)
06-30
2010 (Q1)
03-31
2009 (Q4)
12-31
2009 (Q3)
09-30
2009 (Q2)
06-30
2009 (Q1)
03-31
2008 (Q4)
12-31
2008 (Q3)
09-30
2008 (Q2)
06-30
2008 (Q1)
03-31
2007 (Q4)
12-31
2007 (Q3)
09-30
2007 (Q2)
06-30
2007 (Q1)
03-31
2006 (Q4)
12-31
2006 (Q3)
09-30
2006 (Q2)
06-30
2006 (Q1)
03-31
2005 (Q4)
12-31
2005 (Q3)
09-30
2005 (Q2)
06-30
2005 (Q1)
03-31
2004 (Q4)
12-31
2004 (Q3)
09-30
2004 (Q2)
06-30
2004 (Q1)
03-31
2003 (Q4)
12-31
2003 (Q3)
09-30
2003 (Q2)
06-30
2003 (Q1)
03-31
2002 (Q4)
12-31
2002 (Q3)
09-30
2002 (Q2)
06-30
2002 (Q1)
03-31
2001 (Q4)
12-31
2001 (Q3)
09-30
2001 (Q2)
06-30
2001 (Q1)
03-31
2000 (Q4)
12-31
2000 (Q3)
09-30
2000 (Q2)
06-30
2000 (Q1)
03-31
1999 (Q4)
12-31
1999 (Q3)
09-30
1999 (Q2)
06-30
1999 (Q1)
03-31
1998 (Q4)
12-31
1998 (Q3)
09-30
1998 (Q2)
06-30
1998 (Q1)
03-31
1997 (Q4)
12-31
1997 (Q3)
09-30
1997 (Q2)
06-30
1997 (Q1)
03-31
1996 (Q4)
12-31
1996 (Q3)
09-30
1996 (Q2)
06-30
1996 (Q1)
03-31
1995 (Q4)
12-31
1995 (Q3)
09-30
1995 (Q2)
06-30
1995 (Q1)
03-31
1994 (Q4)
12-31
1994 (Q3)
09-30
1994 (Q2)
06-30
1994 (Q1)
03-31
Report Filing 2022-08-15 2022-08-15 2022-05-16 2022-03-09 2021-11-04 2021-08-05 2021-05-07
1234
Revenue 46.49 10.54 10.43 12.21 13.31 16.06 34.14
1234
Cost of Revenue 8.86 1.69 2.17 2.13 2.87 2.16 6.33
1234
Gross Profit 37.63 8.85 8.26 10.08 10.44 13.9 27.81
1234
Operating Expenses 40.2 9.92 10.3 10.06 9.92 10.11 10.31
1234
Research & Development 2.52 0.154 0.027 1.06 1.28 1.11 1.56
1234
Selling, General and Administrative 37.67 9.76 10.27 9 8.63 9 8.76
1234
Other Operating Expenses 0.006 0.006 0 0 0 0 0
1234
Operating Income -2.57 -1.07 -2.05 0.02 0.525 3.79 17.49
1234
Net Non-Operating Interest -9.95 -2.37 -2.4 -2.44 -2.73 -2.67 -2.61
1234
Interest Income 0.005 0 0 0.005 0 0 0.002
1234
Interest Expense 9.95 2.37 2.4 2.45 2.73 2.67 2.61
1234
Equity & Other Income/(Expense) 16.54 5.92 4.45 6.19 -0.025 2.61 -0.45
1234
Income Before Tax 4.02 2.48 0.003 3.77 -2.23 3.73 14.44
1234
Income Tax Expense 2.5 0.017 0.001 2.45 0.031 0 0.018
1234
Income Attributable to Non-Controlling Interest 0 0 0 0 0 0 0
1234
Net Income 1.52 2.46 0.002 1.32 -2.26 3.73 14.42
1234
Depreciation and Amortization 1.79 0.406 0.456 0.464 0.468 0.486 0.463
1234
EBITDA -0.777 -0.664 -1.59 0.484 0.993 4.28 17.96
1234
Earnings Per Share (EPS) 0.043 0.077 0 0.048 -0.082 0.14 0.53
1234
Diluted Earnings Per Share 0.043 0.077 0 0.048 -0.082 0.11 0.42
1234
Weighted Average Shares Outstanding 32.08 32.08 26.16 27.5 27.5 27.46 27.43
1234
Diluted Weighted Average Shares Outstanding 32.08 32.08 32.92 27.5 27.5 34.2 34.18
1234
discounting cash flows home logo

Discounting Cash Flows

Are you finding our services helpful? Review us on trustpilot logo Trustpilot
Have a question? Contact us
Want to become our sponsor?
Check out our Affiliate Program